Bioelectronics Corp (BIEL)

[GetSeriousOK]

The elephant in the room is the SofPulse trial started in April 2023 by Ilfeld. He may never even bother to analyze the results from the RecoveryRx trial, let alone publish a paper. He owes Whelan nothing -- "he must remain independent" is her oft-repeated quote -- and why waste the time on RecoveryRx if he gets the results he needs from the SofPulse trial?

Leaving poor BIEL at home without a date to the NOPAIN Prom. They don't have the proof that RecoveryRx reduces or eliminates opioid use. Whelan has stated that this proof will come from Ilfeld, but there is certainly no guarantee that he will publish such a paper.

I think Whelan angered Ilfeld when she published letters from participants in Ilfeld's Phantom Pain trial before the trial ended. That is an unforgivable mistake in the world of research. She removed those posts about two weeks later, probably because Ilfeld reprimanded her.

Bottom line -- the NOPAIN Act was a pie in the sky before, but now it's even higher in the sky.